Two Sigma Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102,300
Closed -$9.39M 4232
2021
Q4
$9.39M Sell
102,300
-29,700
-23% -$3.55M 0.02% 826
2021
Q3
$16.7M Sell
132,000
-56,600
-30% -$8.24M 0.04% 537
2021
Q2
$31.4M Buy
188,600
+93,400
+98% +$15.1M 0.07% 334
2021
Q1
$17.3M Buy
95,200
+24,800
+35% +$5.75M 0.05% 494
2020
Q4
$14.1M Sell
70,400
-13,000
-16% -$2.64M 0.04% 478
2020
Q3
$18.3M Buy
83,400
+33,200
+66% +$7.03M 0.06% 321
2020
Q2
$9.58M Buy
50,200
+36,000
+254% +$6.31M 0.05% 404
2020
Q1
$2.2M Sell
14,200
-6,500
-31% -$756K 0.02% 922
2019
Q4
$1.73M Buy
20,700
+15,700
+314% +$1.19M 0.01% 1710
2019
Q3
$339K Buy
+5,000
New +$329K ﹤0.01% 2875
2019
Q1
Sell
-9,000
Closed -$446K 3457
2018
Q4
$446K Buy
+9,000
New +$551K ﹤0.01% 2184

Other funds holding TDOC

Two Sigma Investments's TDOC Position: Q1 2026 in Review

Two Sigma Investments reduced its Teladoc Health (TDOC) stake by 79% in Q1 2026, selling an estimated $3.02M and leaving 138,998 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Two Sigma Investments first reported a position in TDOC in Q1 2016 and has held it in 21 quarters since. The position peaked at $83.7M in Q2 2022. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Two Sigma Investments held 138,998 shares of Teladoc Health worth $758K as of Q1 2026.
  • Two Sigma Investments sold 538,557 Teladoc Health shares in Q1 2026, an estimated $3.02M.
  • Teladoc Health made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3454 holding.
  • Two Sigma Investments first reported a position in Teladoc Health in Q1 2016 and has held it in 21 quarters since.
  • Two Sigma Investments's Teladoc Health position peaked at $83.7M in Q2 2022.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.